Key information

🔎 Fund Overview

IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products include national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; and sub-national offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level. The company also provides workflow analytics, a set of strategic, analytic, and support services for life sciences companies; and real-world evidence solutions, which integrate information from medical claims, prescriptions, electronic medical records, biomarkers, and government statistics that provide information about treatment patterns, disease progression, therapeutic switching, and concomitant diseases and treatments. In addition, the company offers a range of hosted and cloud-based applications, and associated implementation services; AnalyticsLink, software as a service based analytics solution; and MIDAS, which acts as a source of insight into international market dynamics. Further, it provides clinical solutions that help biopharmaceutical companies and clinical research organizations to design, plan, execute, and track clinical trials, as well as it integrates client data with company’s information and proprietary analytics that enable risk-sharing and pay-for-performance programs, network design and management, and population health management for payers and providers. The company primarily serves life science companies, including pharmaceutical, biotechnology, consumer health, and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers, and financial communities. IMS Health Holdings, Inc. was founded in 1954 and is based in Danbury, Connecticut.